Antibody-drug conjugates against multidrug-resistant cancers: Biomarker-guided patient selection, payload engineering, linker chemistry, and bystander effects

Cancer Letters · Published 2026-07-21 · DOI 10.1016/j.canlet.2026.218753

Authors (6)

Ryan Li, Xiang Chen, Qinguo Huang, Hongjian Ling, Kunxiang Gong, Zhe-Sheng Chen

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Li, R., Chen, X., Huang, Q., et al. (2026). Antibody-drug conjugates against multidrug-resistant cancers: Biomarker-guided patient selection, payload engineering, linker chemistry, and bystander effects. Cancer Letters. https://doi.org/10.1016/j.canlet.2026.218753

Related articles

• Commentary regarding “Electroacupuncture combined with fruquintinib and sintilimab in microsatellite-stable metastatic colorectal cancer: A phase II study” · Cancer Letters · 2026 · Same journal
• Optimized L1CAM-CAR T cells enhance activity against moderate-antigen-density rhabdomyosarcoma models · Cancer Letters · 2026 · Same journal
• VG161 oncolytic virus remodels the tumor microenvironment by expanding CD3+ macrophages and enhancing antitumor immunity · Cancer Letters · 2026 · Same journal
• GSN liquid-liquid phase separation induces PANoptosis by inhibiting YAP-dependent glycolysis to alleviate the progression of clear cell renal cell carcinoma · Cancer Letters · 2026 · Same journal
• Mechano-activation of osteocytic connexin hemichannels prime microenvironment in suppressing breast cancer bone metastasis · Cancer Letters · 2026 · Same journal
• The m6A epitranscriptome in cancer therapy resistance: From cellular plasticity and metabolic rewiring to immune escape and therapeutic targeting · Cancer Letters · 2026 · Same journal
• Elevated FN14 expression promotes proliferation, chemoresistance, and impairment of differentiation in rhabdomyosarcoma · Cancer Letters · 2026 · Same journal
• Targeting MDA-9/syntenin-1 (SDCBP) as a strategy to eliminate head and neck squamous cell carcinoma stem cells · Cancer Letters · 2026 · Same journal
• Immunotherapy-based combination remodels the immunosuppressive microenvironment and enhances efficacy in advanced SMARCA4-deficient non-small cell lung cancer · Cancer Letters · 2026 · Same journal
• Early-onset lung cancer: etiologic heterogeneity, genomic features, and age-informed clinical management · Cancer Letters · 2026 · Same journal